These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

715 related items for PubMed ID: 19249502

  • 1. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients.
    Malyszko J, Malyszko JS, Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S, Mysliwiec M.
    Transplant Proc; 2009; 41(1):158-61. PubMed ID: 19249502
    [Abstract] [Full Text] [Related]

  • 2. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients.
    Malyszko J, Malyszko JS, Mysliwiec M.
    Clin Transplant; 2009; 23(5):681-6. PubMed ID: 19708926
    [Abstract] [Full Text] [Related]

  • 3. Kidney function assessed by eGFR, cystatin C and NGAL (neutrophil gelatinase-associated lipocalin) in relation to age in heart allograft recipients.
    Przybylowski P, Malyszko J, Malyszko J.
    Med Sci Monit; 2010 Sep; 16(9):CR440-4. PubMed ID: 20802417
    [Abstract] [Full Text] [Related]

  • 4. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in heart allograft recipients.
    Przybylowski P, Malyszko J, Malyszko JS.
    Transplant Proc; 2010 Jun; 42(5):1797-802. PubMed ID: 20620526
    [Abstract] [Full Text] [Related]

  • 5. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
    Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, Malyszko JS, Poniatowski B, Dobrzycki S.
    Ren Fail; 2008 Jun; 30(6):625-8. PubMed ID: 18661413
    [Abstract] [Full Text] [Related]

  • 6. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease.
    Poniatowski B, Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Dobrzycki S.
    Kidney Blood Press Res; 2009 Jun; 32(2):77-80. PubMed ID: 19287180
    [Abstract] [Full Text] [Related]

  • 7. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
    Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Pawlak K, Dobrzycki S.
    Nephrology (Carlton); 2008 Apr; 13(2):153-6. PubMed ID: 18275504
    [Abstract] [Full Text] [Related]

  • 8. Comparative assessment of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C as early biomarkers for early detection of renal failure in patients with hypertension.
    Gharishvandi F, Kazerouni F, Ghanei E, Rahimipour A, Nasiri M.
    Iran Biomed J; 2015 Apr; 19(2):76-81. PubMed ID: 25864811
    [Abstract] [Full Text] [Related]

  • 9. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
    Shen SJ, Hu ZX, Li QH, Wang SM, Song CJ, Wu DD, He JL, Guan JC, Shan JP.
    Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
    [Abstract] [Full Text] [Related]

  • 10. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study.
    Lebkowska U, Malyszko J, Lebkowska A, Koc-Zorawska E, Lebkowski W, Malyszko JS, Kowalewski R, Gacko M.
    Transplant Proc; 2009 Mar; 41(1):154-7. PubMed ID: 19249501
    [Abstract] [Full Text] [Related]

  • 11. Plasma neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine, and glomerular filtration rate in patients after heart and lung transplantation.
    Szewczyk M, Wielkoszyński T, Zakliczyński M, Zembala M.
    Transplant Proc; 2009 Oct; 41(8):3242-3. PubMed ID: 19857721
    [Abstract] [Full Text] [Related]

  • 12. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.
    Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, Nicocia G, Buemi M.
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):337-44. PubMed ID: 19176795
    [Abstract] [Full Text] [Related]

  • 13. Is plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) determination in donors and recipients predictive of renal function after kidney transplantation?
    Buemi A, Musuamba F, Frederic S, Douhet A, De Meyer M, De Pauw L, Darius T, Kanaan N, Wallemacq P, Mourad M.
    Clin Biochem; 2014 Oct; 47(15):68-72. PubMed ID: 25011070
    [Abstract] [Full Text] [Related]

  • 14. Liver fatty-acid-binding protein in heart and kidney allograft recipients in relation to kidney function.
    Przybylowski P, Koc-Zorawska E, Malyszko JS, Kozlowska S, Mysliwiec M, Malyszko J.
    Transplant Proc; 2011 Oct; 43(8):3064-7. PubMed ID: 21996226
    [Abstract] [Full Text] [Related]

  • 15. Neutrophil gelatinase-associated lipocalin: a novel marker of contrast nephropathy risk.
    McCullough PA, Williams FJ, Stivers DN, Cannon L, Dixon S, Alexander P, Runyan D, David S.
    Am J Nephrol; 2012 Oct; 35(6):509-14. PubMed ID: 22627273
    [Abstract] [Full Text] [Related]

  • 16. Serum Neutrophil Gelatinase-Associated Lipocalin and Cystatin C for Assessing Recovery of Graft Function in Patients Undergoing Living-Donor Kidney Transplantation.
    Liu Y, Li HX, Ying ZW, Guo JJ, Cao CY, Jia W, Yang HR.
    Clin Lab; 2016 Oct; 62(1-2):155-63. PubMed ID: 27012045
    [Abstract] [Full Text] [Related]

  • 17. Is neutrophil gelatinase-associated lipocalin an optimal marker of renal function and injury in liver transplant recipients?
    Hryniewiecka E, Gala K, Krawczyk M, Pączek L.
    Transplant Proc; 2014 Oct; 46(8):2782-5. PubMed ID: 25380917
    [Abstract] [Full Text] [Related]

  • 18. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.
    Bolignano D, Lacquaniti A, Coppolino G, Campo S, Arena A, Buemi M.
    Kidney Blood Press Res; 2008 Oct; 31(4):255-8. PubMed ID: 18600028
    [Abstract] [Full Text] [Related]

  • 19. Plasma neutrophil gelatinase-associated lipocalin as a marker for the prediction of worsening renal function in children hospitalized for acute heart failure.
    Elsharawy S, Raslan L, Morsy S, Hassan B, Khalifa N.
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):49-54. PubMed ID: 26787566
    [Abstract] [Full Text] [Related]

  • 20. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
    Xiang D, Zhang H, Bai J, Ma J, Li M, Gao J, Wang C.
    Int J Clin Exp Pathol; 2014 Jan; 7(10):7172-81. PubMed ID: 25400814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.